A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 ...

Discover the molecular mechanisms behind severe blood clots linked to specific COVID-19 vaccines, revealing crucial insights for future vaccine safety.

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

In Switzerland, 0.02% of the population lives beyond the age of 100. Could there be biological characteristics associated ...

Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.

The beta cells in our pancreas act as highly sensitive sensors that constantly measure the amount of sugar in our blood. As soon as we eat something and the sugar level rises, the beta cells produce ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.

Scientists have mapped a direct link between a common brain gas and the hyperactive cell growth often seen in autism. Protecting a specific protein from this gas normalized behavior in animal models ...

UCB secured worldwide exclusive rights to develop, manufacture, and commercialize ATG-201, including access to Antengene’s enabling manufacturing technology for this bispecific T-cell engager modality ...